While this may seem like a small number, those who have not prescribed the drug are unaccounted for. Users may experience withdrawals, which can lead to an addiction to Benzodiazepines. Although there are many risks, benzodiazepines are essential therapies, but are often misused and combined with other drugs or alcohol, claims FDA commissioner Stephen M. Hahn. This is one of the reasons why the label change is so important. It will allow a user to refrain from combining drugs or limiting the amount they take. Mental health ties into the abuse of Benzodiazepine because those who suffer from mental health are prescribed these drugs. If patients receive drugs classified as Benzodiazepines and are possible risks to themselves (suicidal), there is a high chance of substance abuse, which will most likely lead to suicidal ideation. Many people taking the drug as medication are often misinformed about the dangers of taking it mixed with other medicines. The specification described previously will be written on the bottles of the medication. The labeling change will potentially generate professionals to be more aware of their drug prescriptions and the risks associated. Designs by: Jessie King and Manasi Narsina
38 Publizr Home